Wikidata

(Q73021186)

English

No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study Group

scientific article published on 01 August 1999

In more languages

Statements

title
No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study Group (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10497848
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10497848%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 October 2019
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q73021186&oldid=1760121227"